Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 12, 2026, 6:27 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 1105–1128 of 2,512 matching trials from the live ClinicalTrials.gov search.

Filters: Intervention: RAPID Clear all

Conditions: Type 1 Diabetes
Interventions: Insulin, Insulin LISPRO; Drug
Lead sponsor: Hompesch, Marcus, M.D.; Individual
Eligibility: 18 Years to 65 Years
Enrollment: 20 participants
Healthy volunteers: Healthy volunteers not accepted
U.S. locations: 1
States / cities: Chula Vista, California

Conditions: Healthy
Interventions: Lofexidine HCl; Drug
Lead sponsor: USWM, LLC (dba US WorldMeds); Industry
Eligibility: 18 Years to 50 Years
Enrollment: 13 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2011
U.S. locations: 1
States / cities: San Antonio, Texas

Conditions: Multiple Myeloma
Interventions: Bortezomib (VELCADE), Doxorubicin hydrochloride (DOXIL/CAELYX); Drug
Lead sponsor: Janssen Research & Development, LLC; Industry
Eligibility: 18 Years and older
Enrollment: 646 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2004 – 2014
U.S. locations: 28
States / cities: Alabaster, Alabama • Surprise, Arizona • Berkeley, California + 25 more

Conditions: Fasting, Non-alcoholic Fatty Liver Disease (NAFLD)
Interventions: Fasting, Diet, oral carbohydrate challenge; Behavioral · Dietary Supplement
Lead sponsor: Beth Israel Deaconess Medical Center; Other
Eligibility: 18 Years to 60 Years
Enrollment: 40 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2009 – 2023
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Influenza, Pneumonia
Interventions: oseltamivir; Drug
Lead sponsor: University of Louisville; Other
Eligibility: 18 Years and older
Enrollment: 1,107 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2010 – 2016
U.S. locations: 5
States / cities: Louisville, Kentucky

Conditions: Hypercholesterolemia, Hyperlipidemia, Vitamin Deficiency, Obesity
Interventions: Fortified eggs, Intermittent fasting, Non-egg supplemented, Usual care diet; Dietary Supplement · Behavioral
Lead sponsor: Duke University; Other
Eligibility: 50 Years and older
Enrollment: 140 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2022
U.S. locations: 1
States / cities: Durham, North Carolina

Conditions: Cystinosis
Interventions: RP103; Drug
Lead sponsor: Amgen; Industry
Eligibility: Up to 6 Years
Enrollment: 17 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012 – 2016
U.S. locations: 1
States / cities: Chicago, Illinois

Conditions: Schizophrenia, Psychosis, Schizoaffective Disorder, Schizophreniform Disorders, Psychosis NOS, Depression Psychotic Feature, Bipolar Disorder With Psychotic Features, Unspecified Psychosis
Interventions: Targeted Cognitive Training, General Cognitive Exercises, Coordinated Specialty Care for First Episode Psychosis; Device · Other
Lead sponsor: University of Minnesota; Other
Eligibility: 16 Years to 35 Years
Enrollment: 45 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2022
U.S. locations: 1
States / cities: Minneapolis, Minnesota

Conditions: Mental Health
Interventions: IMPACT Methods to Identify and Prioritize Determinants (Challenge I), Challenge and Match strategies to Prioritized Determinants (Challenge II); Behavioral
Lead sponsor: Kaiser Permanente; Other
Eligibility: 18 Years and older
Enrollment: 76 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2022 – 2025
U.S. locations: 1
States / cities: Seattle, Washington

Conditions: PTSD - Post Traumatic Stress Disorder, Cognitive Dysfunction, Brain Injury, Depression - Major Depressive Disorder, Suicidal Ideation
Interventions: Magnetic e-Resonance Therapy (MeRT), Ibogaine Hydrochloride with Magnesium Sulfate, 5-methoxy-N,N-dimethyltryptamine, Physiological Supplementation; Device · Drug
Lead sponsor: Axial Therapeutic Research; Industry
Eligibility: 18 Years and older
Enrollment: 52 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2022 – 2026
U.S. locations: 1
States / cities: Northridge, California

Conditions: Aerobic Endurance, Metabolism
Interventions: High-amylose maize starch+acetate/butyrate, Low-amylose maize starch; Dietary Supplement · Other
Lead sponsor: United States Army Research Institute of Environmental Medicine; Federal
Eligibility: 17 Years to 39 Years
Enrollment: 21 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2023 – 2025
U.S. locations: 1
States / cities: Natick, Massachusetts

Conditions: Type 1 Diabetes Mellitus
Interventions: Humalog, Novolog, BC222 insulin lispro, Bionic Pancreas; Drug · Device
Lead sponsor: Massachusetts General Hospital; Other
Eligibility: 18 Years and older
Enrollment: 20 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: HIV, Substance Abuse, HIV Infections
Interventions: Intensive Case Management; Behavioral
Lead sponsor: Yale University; Other
Eligibility: 18 Years and older
Enrollment: 127 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2008 – 2013
U.S. locations: 2
States / cities: New Haven, Connecticut • Waterbury, Connecticut

Conditions: HIV Infections
Interventions: Patient-centered injection site, Patient-centered adherence support, Provider education, Improved clinic communication strategies; Other · Behavioral
Lead sponsor: Public Health Foundation Enterprises, Inc.; Other
Eligibility: 18 Years and older · Male only
Enrollment: 50 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2024
U.S. locations: 1
States / cities: San Francisco, California

Conditions: Substance Use Disorders, Recidivism
Interventions: Adolescent Community Reinforcement Approach, Assertive Continuing Care, Trauma Affect Regulation Guide for Education and Therapy, Motivational Interviewing, Opioid Education Workbook; Behavioral · Other
Lead sponsor: Seattle Children's Hospital; Other
Eligibility: 15 Years to 25 Years
Enrollment: 215 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2024
U.S. locations: 1
States / cities: Olympia, Washington

Conditions: Hypertension
Interventions: Improve clinic based measurement of blood pressure, Provider education system to promote patient-centered care, Introduce care management system in clinics; Behavioral
Lead sponsor: Johns Hopkins University; Other
Eligibility: 18 Years and older
Enrollment: 66,570 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2011 – 2015
U.S. locations: 1
States / cities: Baltimore, Maryland

Conditions: Stress Urinary Incontinence
Interventions: Electric DN, NM Re-ed, Exercise; Other
Lead sponsor: Alabama Physical Therapy & Acupuncture; Other
Eligibility: 35 Years and older · Female only
Enrollment: 24 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2019
U.S. locations: 1
States / cities: Columbia, South Carolina

Conditions: Healthy Volunteers, Speech
Interventions: Altered Auditory Feedback (AAF), Visual-Acoustic Biofeedback; Behavioral
Lead sponsor: New York University; Other
Eligibility: 18 Years to 45 Years
Enrollment: 40 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2026
U.S. locations: 1
States / cities: New York, New York

Conditions: Coronary Artery Disease, CAD
Interventions: regadenoson, Optimark®, Myocardial perfusion MRI; Drug · Device
Lead sponsor: Daniel S. Berman; Other
Eligibility: 18 Years and older
Enrollment: 44 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2017
U.S. locations: 1
States / cities: Los Angeles, California

Conditions: Colorectal Cancer
Interventions: 5-Fluorouracil, Leucovorin, Capecitabine [Xeloda]; Drug
Lead sponsor: Hoffmann-La Roche; Industry
Eligibility: 18 Years to 75 Years
Enrollment: 1,987 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 1998 – 2004
U.S. locations: 17
States / cities: Birmingham, Alabama • Phoenix, Arizona • Fountain Valley, California + 14 more

Conditions: Healthy Volunteers
Interventions: GDC-0134 F09 Formulation, GDC-0134 F15 Formulation, GDC-0134 F16 Formulation; Drug
Lead sponsor: Genentech, Inc.; Industry
Eligibility: 18 Years to 65 Years · Female only
Enrollment: 38 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2019
U.S. locations: 2
States / cities: Daytona Beach, Florida • Dallas, Texas

Conditions: Tuberculosis
Interventions: PA-824 200mg, PA-824 50mg; Drug
Lead sponsor: Global Alliance for TB Drug Development; Other
Eligibility: 19 Years to 50 Years
Enrollment: 32 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2009 – 2010
U.S. locations: 1
States / cities: Lincoln, Nebraska

Conditions: Cellulite
Interventions: Soliton's Rapid Acoustic Pulse (RAP); Device
Lead sponsor: Soliton; Industry
Eligibility: 18 Years to 50 Years · Female only
Enrollment: 67 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2019 – 2021
U.S. locations: 4
States / cities: Scottsdale, Arizona • Chicago, Illinois • Chevy Chase, Maryland + 1 more

Conditions: HIV
Interventions: Reducing Risk Behavior, Support and Guidance; Behavioral
Lead sponsor: Emory University; Other
Eligibility: 18 Years to 24 Years
Enrollment: 2 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2015 – 2017
U.S. locations: 2
States / cities: Atlanta, Georgia

Search by objective public record fields.

PK/PD Study of Intranasal Insulin in Type I Diabetes

Lofexidine Food Effect Study in Healthy Volunteers

Study of DOXIL/CAELYX (Pegylated Liposomal Doxorubicin) and VELCADE (Bortezomib) or VELCADE Monotherapy for the Treatment of Relapsed Multiple Myeloma

Regulation of FGF21 by Nutritional Challenges

Rapid Empiric Treatment With Oseltamivir Study (RETOS)

PROSPective Evaluation of Fortified Eggs Related to Improvement in The Biomarker Profile for Your Health

Safety/Effectiveness Study of Cysteamine Bitartrate Delayed-release Capsules (RP103) in Cysteamine Treatment Naive Patients With Cystinosis

Minnesota Community-Based Cognitive Training in Early Psychosis

Novel Methods for Implementing Measurement-Based Care for Youth in Low-resource Environments

Trifecta Research Study

Effect of Short-chain Fatty Acids on Aerobic Endurance

Individualizing Automated Closed Loop Glucose Control Through Pharmacokinetic Profiling in an Insulin-Only Bionic Pancreas

Transitions: Linkages From Jail To Community

The Cheeky Study: A Novel Delivery System for CAB-RPV LA

Preventing OUD in Justice-Involved Youth

Multi-Method Health System Quality Improvement Intervention to Reduce Hypertension Disparities

Neuromuscular Re-eduaction, Exercise and Electric Dry Needling vs. Neuromuscular Re-education and Exercise for Stress Urinary Incontinence

Prediction of Visual Feedback Effects on Speech Motor Adaptation in Healthy Adults

Artifact-Free High-Resolution Myocardial Perfusion MRI in Subjects With Abnormal Nuclear Myocardial Perfusion Studies

A Study of Xeloda (Capecitabine) Compared With 5-Fluorouracil in Combination With Low-Dose Leucovorin in Patients Who Have Undergone Surgery for Colon Cancer

A Study to Determine the Bioavailability of Various Formulations of GDC-0134 in Healthy Female Participants of Non-Childbearing Potential

Food Effect Study on the Bioavailability and PK of PA-824 Tablets in Healthy Adult Subjects (CL-009)

Study of the Soliton Rapid Acoustic Pulse (RAP) Device for the Treatment of Cellulite

The Georgia Latino AIDS/HIV Diagnosis and Linkage in Youth (GLADLY) Project